MAMeshal Alzakari

Meshal Alzakari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meshal Alzakari has a total of 153 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Understanding Osteomyelitis in Saudi Arabia’s Adult Population: A Nationwide Cross-Sectional Study of Knowledge and Attitudes

    by Yousef M Alammari, Abdullah Alghamdi, Abdulwahed A Alotay, Abdulrahman Alanazi, Mohammad Alhajery, Rayan A Qutob, Tariq Yousef Alhomoud, Osama Thamer Al-Ahmari, Ammar Yasser AL Qahtani, Muath Alamri, et al.

    Background: Osteomyelitis (OM) is a severe bone infection causing progressive destruction. This nationwide cross-sectional study evaluated public knowledge and attitudes regarding OM among Saudi Arabian adults to identify sociodemographic gaps and guide targeted health education. Methods: Saudi residents aged ≥ 18 years completed a validated electronic survey. Knowledge was evaluated using a 7-item score (good awareness defined as ≥ 60% correct). Bivariate testing and multivariable binary logistic regression were conducted using SPSS version 26 (significance set at p ≤ 0.05). Results: Among 1206 respondents (97.0% Saudi; 58.7% bachelor’s degree), overall awareness was low, with only 38.4% demonstrating good knowledge. Key misconceptions included misclassifying OM as autoimmune (25.3%) or contagious via blood transfusion (26.0%). Multivariable regression revealed that younger age (18– 29 years: aOR = 6.85, 95% CI: 2.38– 19.72, p < 0.001) and bachelor’s education (aOR = 1.42, 95% CI: 1.10– 1.83, p = 0.007) were independent predictors of good awareness. Most participants recognized OM as a serious condition (73.4%) and agreed early detection prevents complications (86.2%). Conclusion: Public awareness of osteomyelitis in Saudi Arabia is markedly low, particularly among older adults and individuals without higher education. Targeted educational strategies integrated into primary healthcare and diabetic foot screening programs are urgently needed.

  • Open Access

    Domain-specific psychosocial and functional impairment in adults with atopic dermatitis: A nationwide cross-sectional study from Saudi Arabia

    by Mohammed Almashali, Ibrahim M. Aseeri, Yazeed Ibrahim Alfarhan, Muteb Mutlaq Alotaibi, Abdulmajeed Ali Alotaibi, Abdulelah F. Alshehri, Abdulmohsen S. Alanazi, Bandar M. Alotaibi, Abdulrahman Alhaddad, Rana Alhazzani, et al.

    A BSTRACT: Background: Although atopic dermatitis (AD) substantially impairs quality of life, whether this burden is distributed uniformly across patient-reported domains and demographic subgroups remains insufficiently characterized. Methods: In this nationwide cross-sectional study, adults with physician-diagnosed AD completed the Dermatology Life Quality Index (DLQI). Domain-specific impairment and demographic associations were evaluated using effect-size–based analyses. Results: Among 886 participants, quality-of-life impairment followed a distinct hierarchical pattern rather than affecting all domains equally. Pruritus/pain (mean DLQI 1.31 ± 0.91), clothing limitations (1.22 ± 1.01), and embarrassment (1.10 ± 0.99) emerged as the principal contributors to disease burden, whereas work and study were least affected (0.50 ± 0.68). Gender demonstrated the strongest association with domain-specific impairment (Cramer’s V up to 0.432), followed by age (0.267), while regional differences remained consistently small. Conclusion: AD burden is multidimensional and hierarchically distributed across patient-reported domains rather than uniformly affecting daily life. Domain-specific assessment may therefore provide a more accurate representation of patient burden than global quality-of-life measures alone and support more individualized management.

  • Open Access

    Determinants of uremic pruritus severity among patients undergoing chronic hemodialysis: A cross-sectional study

    by Abdullah Hussien Alghamdi, Khalid Hamed Alhougail, Sulaiman Abdullah Alraqibah, Reem Hammad Albalawi, Laila Mohammed Mujarribi, Salman Alrasheed, Momen Hashim HajHassan Mohamed, Noor Abdulhakim Alfateel, Faisal Alzkari, Ziyad Alsulami, et al.

    Uremic pruritus, also called chronic kidney disease-associated Pruritus (CKD-aP), is a symptom of severe and ongoing itching that patients with CKD or end-stage renal disease frequently experience. The purpose of this study was to evaluate the factors associated with moderate-to-severe uremic pruritus in patients receiving chronic hemodialysis. This cross-sectional study was conducted at Dr Sulaiman Al-Habib Hospital in Riyadh, Saudi Arabia, from June to October 2025. The severity of itching was assessed using a single-item scale from 0 to 10, with 0 indicating no itching and 10 indicating maximum itching. Responses of >0 were summed to obtain itching intensity. Among participants, 53 (57.0%) were male. The prevalence of severe itching among participants was 10.8%, with a mean itching scale score of 2.35 ± 2.85 out of 10. The noncitizen participants showed higher itching scores than Saudi patients, with a difference that reached the threshold of statistical significance (4.00 ± 3.43) and (2.18 ± 2.75), respectively. Multivariable logistic regression identified that females were 4 times more likely to have moderate-to-severe itching than males (aOR: 5.64 [95% CI: 1.39–22.99]). The majority of hemodialysis patients had minor uremic pruritus. Further research involving larger samples is also warranted to investigate the factors contributing to uremic pruritus in hemodialysis patients.

  • Open Access

    Health-related quality of life for patients on hemodialysis in Saudi Arabia: A cross-sectional study

    by Abdullah Hussien Alghamdi, Khalid Hamed Alhougail, Sulaiman Abdullah Alraqibah, Reem Hammad Albalawi, Laila Mohammed Mujarribi, Salman Alrasheed, Momen Hashim HajHassan Mohamed, Noor Abdulhakim Alfateel, Faisal Alzkari, Ziyad Alsulami, et al.

    The health-related quality of life (HRQoL) for hemodialysis (HD) patients is typically lower than that of kidney transplant patients. Considering that HRQoL is significant for the treatment and well-being of HD patients, this study aimed to evaluate HRQoL among patients undergoing HD in Saudi Arabia. This is a cross-sectional study that was conducted at Dr Sulaiman Al-Habib Hospital in Riyadh, Saudi Arabia, between June and October 2025. Multivariable logistic regression analysis was performed to examine factors associated with physical and mental health outcomes. This study included 93 HD patients. Males had significantly higher PCS (65.72 ± 29.44) and MCS (72.01 ± 23.70) compared to females (PCS: 45.31 ± 29.75; MCS: 56.17 ± 27.18; P < .001). Educational level significantly differed with MCS ( P = .02), with high school graduates and postgraduate degree holders having higher MCS scores. Employment status was also differed in both PCS ( P < .001) and MCS ( P = .02). Higher itching in the past 24 hours was associated with lower odds of both PCS (adjusted odds ratio (aOR) = 0.76, 95% confidence intervals [CI]: 0.61–0.96, P = .018) and MCS (aOR = 0.64, 95% CI: 0.48–0.85, P = .002). for mental health, being Saudi national (aOR = 0.05, 95% CI: 0.00–0.98, P = .048), having a high school education (aOR = 17.74, 95% CI: 1.99–158.18, P = .010), being a student (aOR = 0.01, 95% CI: 0.00–0.55, P = .024), spending 1 to 5 years (aOR = 0.18, 95% CI: 0.03–1.00, P = .050), were all associated with higher MCS scores. The current study revealed that males had significantly higher PCS and MCS than females. Hence, considering these findings is essential to developing efficacious targeted interventions to improve HRQoL among patients on HD, particularly those with lower PCS and/or MCS scores. Further studies are required to explain differences in PCS and/or MCS scores among certain patients’ demographic groups.


  • Open Access

    Treatment outcomes and safety of metformin versus insulin in gestational diabetes mellitus: A systematic review and meta-analysis

    by Khalid Al-Nemer, Hala Alruwaili, Ayesha Alnashwan, Marwa Akram, Maan Almuzaini, Arwa Aloraini, Rahaf Alsaedi, Basil Alshammari, Layin Almasoud, Musab Alsulami, et al.

    A BSTRACT: Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and neonatal outcomes. While insulin remains the traditional treatment, metformin has emerged as a potential alternative due to its ease of use and favorable metabolic effects. This systematic review and meta-analysis aimed to compare the efficacy and safety of metformin versus insulin in the management of GDM. This review was registered with International Prospective Register of Systematic Reviews (PROSPERO) (CRD42025644196) and conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed using PubMed and Google Scholar for studies published between 2020 and 2025. Eligible studies were randomized controlled trials (RCTs) comparing metformin and insulin in pregnant women diagnosed with GDM and reporting relevant maternal or neonatal outcomes. Data screening and extraction were performed using Rayyan software. Statistical analysis was conducted using Stata version 17. Pooled effect sizes were calculated using a random-effects model. Standardized mean differences (SMDs) and odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess continuous and dichotomous outcomes, respectively. Heterogeneity was evaluated using the I² statistic and Cochran’s Q test. Publication bias was assessed using funnel plots and Egger’s test. Twenty-two RCTs met the inclusion criteria. Metformin achieved glycemic control comparable to insulin, with a pooled SMD for fasting blood glucose (FBG) of –0.29 (95% CI: –0.55 to –0.03; P = 0.03). No significant difference was observed in glycated hemoglobin (HbA1c) levels (SMD = –0.26; 95% CI: –0.75 to 0.23; P = 0.30). Metformin was associated with significantly less maternal weight gain and a reduced risk of neonatal hypoglycemia (OR = 2.72; 95% CI: 1.02–7.26; P = 0.05). The incidence of pre-eclampsia and hypertensive disorders was similar between groups. Patient satisfaction was consistently higher in the metformin group, with most participants preferring it over insulin. Funnel plots and Egger’s test indicated no significant publication bias. Metformin is a safe and effective alternative to insulin for the management of GDM in most pregnant women, offering comparable glycemic control, reduced maternal weight gain, lower risk of neonatal hypoglycemia, and higher patient acceptability. While some patients may still require insulin supplementation, metformin represents a valuable first-line option, especially in settings where injection therapy is less feasible or poorly tolerated.

  • Open Access

    Exudative Retinal Detachments: A Rare Adverse Effect of Topiramate

    by Sarah Aljefri, Meshal Alzakari, Bailasan Milibari, Doaa Milibari

    Topiramate‐induced multifocal exudative retinal detachment is a rare but potentially vision‐threatening adverse effect. We report a 59‐year‐old woman with idiopathic intracranial hypertension who developed painless bilateral blurry vision and color desaturation 8 days after initiation of topiramate 25 mg twice daily. Fundus examination and spectral‐domain optical coherence tomography demonstrated bilateral multifocal exudative retinal detachment with subretinal fluid. Extensive infectious and inflammatory investigations were unremarkable. Topiramate was discontinued, resulting in complete anatomical resolution of subretinal fluid and improvement of visual acuity to 20/30 in both eyes over 3 months of follow‐up. This case highlights the importance of recognizing this uncommon ocular complication and the potential for complete recovery following prompt drug cessation.

  • Open Access

    Misconceptions Regarding Mammography Breast Cancer Screening in Saudi Arabia

    by Salahuddin Khan, Meshal Alzakari, Renad Alsuhaibani, Alanoud Alabdulkarim, Amjad Alghanmi, Abdulrahman Alkanhal, Muhammad Umer Abdul Moiz, Amra Salahuddin, Arwa Huda

    Background: Breast cancer is the most common cancer among women and a major cause of mortality. In Saudi Arabia, it accounts for 14.2% of female cancer cases, with an 8.4% mortality rate. Misconceptions about breast cancer and mammography screening contribute to delays in diagnosis and low screening participation. Objective: To identify common misconceptions about breast cancer and mammography in Saudi Arabia. Methods: A cross-sectional study was conducted among 930 women living in Saudi Arabia and aged 18 and above. Participants completed an Arabic online questionnaire to evaluate their knowledge and beliefs. Results: The study revealed significant misconceptions about mammography among Saudi women, including perceived pain (32.5%), embarrassment (41.1%), and privacy concerns. Nearly half (50.4%) were unaware of mammography, and overall breast cancer screening awareness was low (67.8% poor awareness). Higher education, employment, and social connections to individuals diagnosed with breast cancer were significantly linked with better awareness and screening practices. Conclusion: Significant misconceptions and low awareness regarding mammography persist among Saudi women, hindering early breast cancer detection. Targeted educational campaigns addressing myths and ensuring culturally sensitive screening environments are urgently needed. Categories: Family Medicine, Internal Medicine

  • Open Access

    Factors influencing breast self-exam practice and awareness among females in Saudi Arabia

    by Salahuddin Khan, Faisal Alzkari, Alanoud Alabdulkarim, Renad Alsuhaibani, Abdulrahman Alkanhal, Amjad Alghanmi, Amra Salahuddin, Arwa Huda, Muhammad Umer Abdul Moiz, Maan Almuzaini, et al.

    Breast cancer is the most prevalent cancer among women, characterized by the uncontrolled growth of abnormal breast cells. Breast self-examination (BSE) is a simple and cost-effective method for early detection. To examine factors influencing the awareness and practice of BSE among females in Saudi Arabia, and to identify the determinants that affect breast cancer awareness and BSE practices among Saudi women. A cross-sectional study was conducted, targeting females aged 18–65 years in Saudi Arabia. A sample of 930 participants was recruited via social media, employing an online Arabic questionnaire to evaluate demographics, awareness, attitudes, and BSE practices. Most participants were single (71.3%), held a bachelor’s degree (59.4%), and identified as students (65.5%). Awareness of breast cancer was relatively low, with only 13.5% recognizing that women in their fifties have a higher risk of developing the condition, while 38.1% identified common symptoms. Although 79% had heard of BSE, only 42.6% knew how to perform it correctly, and 32.6% understood that BSE is not a substitute for mammograms. Only 21.3% demonstrated good overall awareness of breast cancer and BSE. Higher awareness correlates with older age, higher education, marital status, employment, and personal/family history of breast cancer. BSE awareness and practices among Saudi women are insufficient. Targeted efforts to enhance awareness and BSE practices should focus on younger, less educated, single, and unemployed women to promote regular examination and early detection.


  • Open Access

    Comparative analysis of demographic, behavioral, and nutritional correlates of thyroid disorders in the central region of Saudi Arabia

    by Abdulrhman A. Almazrou, Abdulelah F. Alshehri, Mohammad A. Majrashi, Meshal Alzakari, Rana A. Alhazzani, Yazeed I. Alfarhan, Faysal K. Bindayel, Fahad Mohammed Alomairini, Zyad Azzam Almishaal, Saeed Bin Ayed Al-Sadain, et al.

    A BSTRACT: Background: Thyroid disorders are a significant public health concern in Saudi Arabia, yet data on public awareness and associated behavioral factors remain limited. This study aims to assess and compare the demographic, behavioral, and nutritional awareness of thyroid disorders between healthy individuals and those with a diagnosed condition in Riyadh, Saudi Arabia. Methods: A cross-sectional study was conducted in September 2025, involving 697 participants aged 18 and older. A validated, self-administered questionnaire was distributed online to assess demographics, medical history, and awareness of thyroid disorders and related nutritional factors. Data were analyzed using RStudio, with Chi-square tests used to examine associations between disease status and awareness variables. Results: The study included 581 healthy participants and 116 with thyroid disorders. Females predominated in the thyroid disease group (88% vs. 50%). Participants with thyroid disorders demonstrated significantly higher awareness of risk factors ( P < 0.001), symptoms ( P < 0.001), and the role of iodine ( P = 0.040). Those with a diagnosis were more likely to cite healthcare professionals as their primary information source (58%), whereas healthy individuals relied on informal sources. Notably, nearly half of all respondents (46.5%) had never been tested for thyroid function. Conclusion: Although individuals with a thyroid disorder have greater knowledge, public awareness among the general population in Riyadh is insufficient, with a heavy reliance on non-professional sources. Targeted educational initiatives are required to improve health literacy, encourage proactive screening, and address misconceptions, particularly among younger adults and males, to reduce the burden of thyroid disease.

  • Open Access

    Skin Barrier Modulation and Survival-Relevant Outcomes: A Systematic Review of Topical Emollients in Preterm Infants

    by Abdulelah F. Alshehri, Mohammad Majrashi, Abdulmohsen Alanazi, Khalid Alshammari, Rana Alhazzani, Meshal Alzakari, Ayad A. Bagazi, Abdullatif Aldhafyan, Faisal Alqarni, Khalid Almubarak, et al.

    Preterm neonates have an immature skin barrier that predisposes them to excessive water loss, microbial colonization, and systemic infection. Topical emollient therapy has been proposed as a low-cost strategy to support barrier function. However, the extent to which clinical benefits reflect direct permeability changes versus downstream biological effects remains unclear. A systematic review was conducted in accordance with PRISMA 2020. PubMed, the Cochrane Library, and Google Scholar were searched from inception to January 31, 2025. Randomized or quasi-randomized controlled trials evaluating topical emollients in preterm neonates and reporting direct or proxy skin barrier-related outcomes were included. Due to substantial heterogeneity, results were synthesized narratively following the Synthesis Without Meta-analysis (SWiM) framework. Risk of bias was assessed using Risk of Bias Tool 2 (ROB-2), and certainty of evidence was evaluated using GRADE. Seven randomized studies met the inclusion criteria. Only one preterm trial directly measured transepidermal water loss (TEWL) and demonstrated a significant reduction with coconut oil. Three trials reported improved neonatal skin condition scores (NSCS) with emollient therapy. Proxy outcomes included reduced skin deterioration, altered microbial profiles, and lower rates of culture-proven sepsis. A reduction in neonatal mortality was observed in one large trial conducted in a low-resource hospital setting. Heterogeneity in populations, emollient formulations, and outcome measures precluded quantitative meta-analysis. Overall certainty of evidence ranged from low to moderate. Topical emollients are associated with improved skin condition and selected clinical outcomes in preterm neonates, despite limited direct evidence of barrier permeability modification. Observed clinical benefits appear context-dependent and are largely driven by a single large trial. Multidimensional trials integrating biophysical, microbiological, and clinical outcomes are needed to clarify mechanisms and guide targeted clinical application.